Literature DB >> 12902402

Endothelial expression of the alpha6beta4 integrin is negatively regulated during angiogenesis.

Tejindervir S Hiran1, Joseph E Mazurkiewicz, Paul Kreienberg, Frank L Rice, Susan E LaFlamme.   

Abstract

Development and homeostasis of the vascular system requires integrin-facilitated cellular adhesion, migration, proliferation and survival. A specific role for the alpha6beta4 integrin in the vasculature, however, has not been identified. Using immunohistochemistry, we observed alpha6beta4 expression on the dermal microvasculature of human foreskin. Analysis of individual cells isolated from trypsin-disrupted foreskin tissue indicated that alpha6beta4 was expressed by a subset of epithelial and endothelial cells, and not by smooth muscle cells. Expression of alpha6beta4 was also analyzed during new vessel growth using explants of human saphenous vein cultured in fibrinogen gels. The results indicate that alpha6beta4 is not expressed by outgrowing endothelial cells, and is downregulated by the original alpha6beta4-positive endothelial cells of the explant. To determine whether alpha6beta4 is expressed during angiogenesis in vivo, the expression of the beta4 subunit was analyzed during the development of the mouse mystacial (whisker) pad. Immunohistochemical staining of the whisker pad indicates that beta4 is expressed by the adult vasculature. To identify when and where beta4 is turned on in the vasculature, we examined the whisker pads from the developing embryo (E19.5 pc), and from postnatal days zero (P0), three (P3) and seven (P7) pups. The expression of alpha6beta4 was found to be turned on spatially and temporally from caudal to rostral regions and from the deep to superficial vasculature, correlating with the maturation of the whisker pad and its corresponding vasculature. Together, these findings suggest a potential role for alpha6beta4 as a negative component of the angiogenic switch, whereas expression of alpha6beta4 on the adult vasculature may indicate regions requiring additional adhesive mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902402     DOI: 10.1242/jcs.00681

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  13 in total

1.  β4 integrin marks interstitial myogenic progenitor cells in adult murine skeletal muscle.

Authors:  Kalliopi Liadaki; Juan Carlos Casar; McKenzie Wessen; Eric S Luth; Susan Jun; Emanuela Gussoni; Louis M Kunkel
Journal:  J Histochem Cytochem       Date:  2012-01       Impact factor: 2.479

Review 2.  Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.

Authors:  Shi Xu; Bogdan Z Olenyuk; Curtis T Okamoto; Sarah F Hamm-Alvarez
Journal:  Adv Drug Deliv Rev       Date:  2012-09-29       Impact factor: 15.470

Review 3.  Non-angiogenic functions of VEGF in breast cancer.

Authors:  Arthur M Mercurio; Elizabeth A Lipscomb; Robin E Bachelder
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

4.  Dynamic Regulation of Integrin α6β4 During Angiogenesis: Potential Implications for Pathogenic Wound Healing.

Authors:  Diana Desai; Purva Singh; Livingston Van De Water; Susan E Laflamme
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-10       Impact factor: 4.730

5.  Endothelial β4 integrin is predominantly expressed in arterioles, where it promotes vascular remodeling in the hypoxic brain.

Authors:  Jennifer V Welser-Alves; Amin Boroujerdi; Ulrich Tigges; Lawrence Wrabetz; M Laura Feltri; Richard Milner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-07       Impact factor: 8.311

6.  Upregulation and redistribution of integrin alpha6beta4 expression occurs at an early stage in pancreatic adenocarcinoma progression.

Authors:  Zobeida Cruz-Monserrate; Suimin Qiu; B Mark Evers; Kathleen L O'Connor
Journal:  Mod Pathol       Date:  2007-04-13       Impact factor: 7.842

Review 7.  Review of Integrin-Targeting Biomaterials in Tissue Engineering.

Authors:  Prachi Dhavalikar; Andrew Robinson; Ziyang Lan; Dana Jenkins; Malgorzata Chwatko; Karim Salhadar; Anupriya Jose; Ronit Kar; Erik Shoga; Aparajith Kannapiran; Elizabeth Cosgriff-Hernandez
Journal:  Adv Healthc Mater       Date:  2020-09-16       Impact factor: 9.933

8.  Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation.

Authors:  Stephan Niland; Johannes A Eble
Journal:  J Oncol       Date:  2011-09-18       Impact factor: 4.375

9.  Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF.

Authors:  Rita Graça da Silva; Bernardo Tavora; Stephen D Robinson; Louise E Reynolds; Charles Szekeres; John Lamar; Sílvia Batista; Vassiliki Kostourou; Mitchel A Germain; Andrew R Reynolds; Dylan T Jones; Alan R Watson; Janet L Jones; Adrian Harris; Ian R Hart; M Luisa Iruela-Arispe; C Michael Dipersio; Jordan A Kreidberg; Kairbaan M Hodivala-Dilke
Journal:  Am J Pathol       Date:  2010-07-16       Impact factor: 4.307

Review 10.  The aortic ring model of angiogenesis: a quarter century of search and discovery.

Authors:  R F Nicosia
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.